Astaxanthin Regulates PPAR-<i>γ</i>/NF-<i>κ</i>B Pathway to Mitigate Nerve Injury after Cerebral Ischemia/Reperfusion in Rats

Miao Huo, Qian Zhang, Ziyu Zhao, Ruifen Xu, Xingxing Zheng, Guang Yang, Jiao GuoJournal of Biosciences and Medicines 2022 · DOI

Abstract

This research evaluates the efficacy of Astaxanthin (AX) on cerebral ischemia/reperfusion (I/R) injury in rats and elucidates the potential mechanism of its neuronal protective effect. Using a middle cerebral artery occlusion/reperfusion (MCAO/R) model and lipopolysaccharide (LPS)-stimulated rat microglia (RM), the study found that AX inhibits microglial activation and enhances PPAR-γ expression in a dose-dependent manner. The results demonstrate that AX alleviates infarct volume and improves functional recovery by regulating the PPAR-γ/NF-κB signaling pathway.

Introduction

Ischemic stroke remains a leading cause of global mortality and long-term disability. While reperfusion is necessary to save brain tissue, it often triggers a secondary wave of damage known as ischemia/reperfusion (I/R) injury. A central player in this process is the over-activation of microglia, the brain's resident immune cells. When activated, microglia release pro-inflammatory cytokines (such as IL-1β, IL-6, and TNF-α) that exacerbate neuronal death. This study investigates whether Astaxanthin, a natural carotenoid with potent antioxidant properties, can mitigate this inflammatory response by targeting the PPAR-γ/NF-κB axis.

Methods

The study utilized both in vivo and in vitro models:

  • Animal Model: Sprague-Dawley rats underwent MCAO/R to simulate stroke. Treatment groups received AX (10 mg/kg), while mechanism-validation groups received PPAR-γ siRNA or the antagonist GW9662.
  • Cellular Model: Rat Microglia (RM) were stimulated with LPS to induce an inflammatory state and then treated with AX at concentrations of 1, 5, or 10 μg/mL.
  • Evaluations: Researchers measured neurological scores (mNSS), cerebral infarct volume, and the expression of inflammatory markers (CD68, iNOS, CD206) and signaling proteins (PPAR-γ, p-P65) via RT-qPCR and Western Blotting.

Results

Astaxanthin demonstrated significant neuroprotective effects across both models. In rats, AX treatment reduced brain infarct volume and improved sensorimotor and cognitive performance.

In the cellular model, AX treatment suppressed the expression of pro-inflammatory markers while promoting the anti-inflammatory marker CD206. Crucially, AX increased the expression of PPAR-γ protein in a dose-dependent manner. As shown in the data below, increasing concentrations of AX led to a significant reduction in the secretion of inflammatory cytokines like IL-6 and TNF-α, while simultaneously boosting PPAR-γ levels.

Dose-dependent effects of Astaxanthin on microglial activation markers and PPAR-γ expression.

The study further confirmed that the protective effects of AX were neutralized when PPAR-γ was silenced or inhibited, proving that AX works specifically through the PPAR-γ/NF-κB pathway to suppress the "master switch" of inflammation.

Discussion

The findings highlight the PPAR-γ/NF-κB axis as a critical therapeutic target for stroke. By activating PPAR-γ, AX prevents the phosphorylation of P65, thereby inhibiting the NF-κB pathway and reducing the inflammatory storm.

While the results are promising, the study notes limitations: AX was administered as a pre-treatment, which may not reflect emergency clinical scenarios where treatment begins post-stroke. Additionally, while the MCAO/R model is a standard, further research is needed to translate these rodent-based findings into human clinical applications. Future work should also explore AX's potential multi-target effects, including its anti-apoptotic and direct antioxidant properties.

Conclusion

Astaxanthin effectively alleviates LPS-induced microglial injury and provides significant protection against cerebral I/R injury in rats. This neuroprotective effect is primarily mediated by the regulation of the PPAR-γ/NF-κB pathway, suggesting that AX could be a viable therapeutic candidate for mitigating the damage caused by ischemic stroke.

Summary updated

Abstract

Purpose: This research evaluates the efficacy of astaxanthin (AX) on cerebral ischemia/reperfusion (I/R) injury in rats and elucidates the potential mechanism of its neuronal protective effect. Methods: Rats were subjected to a middle cerebral artery occlusion/reperfusion (MCAO/R) model. Fifty grown male Sprague-Dawley (SD) rats were divided into 5 groups, including sham operation group (Sham), MCAO/R group, MCAO/R+AX group, MCAO/R+ AX+ Scramble group and MCAO/R+AX+ si-PPAR-γ group. The neurological score and cerebral infarction volume were evaluated after surgery. Rat microglia (RM) were stimulated by lipopolysaccharide (LPS) to form an inflammatory environment. LPS-induced RM cells were incubated with different concentrations of AX (1, 5 or 10 μg/mL), then cell viability, the expression of microglial activation markers, including cytokines (IL-1β, IL-6 and TNF-α), cluster of differentiation 68 (CD68), inducible nitric oxide synthase (iNOS) and CD206 and the expression of PPAR-γ and phosphorylated P65 (p-P65) proteins were determined. Cells were treated with pcDNA-PPAR-γ, as well as treatment with si-PPAR-γ or PPAR-γ antagonist GW9662 before AX treatment, and then cell activation mediators were tested. Results: AX inhibits LPS-induced RM cells activation and enhanced the expression level of PPAR-γ protein in way of dose-dependent, and pcDNA-PPAR-γ treatment had the same effect as AX. While si-PPAR-γ transfection or PPAR-γ suppressant GW9662 treatment reversed the effect of AX, and cut down the level of PPAR-γ protein and augmented the level of p-P65 protein. In addition, AX treatment alleviated the infarct volume, and sensorimotor and cognitive functions of MCAO/R model rats. Conclusion: AX alleviates LPS-induced microglial injury and has a protective effect on rat cerebral I/R injury by regulating the PPAR-γ/NF-κB pathway.
BibTeX
@article{huo2022astaxanthin,
  author = {Miao Huo and Qian Zhang and Ziyu Zhao and Ruifen Xu and Xingxing Zheng and Guang Yang and Jiao Guo},
  title = {{Astaxanthin Regulates PPAR-\<i\>γ\</i\>/NF-\<i\>κ\</i\>B Pathway to Mitigate Nerve Injury after Cerebral Ischemia/Reperfusion in Rats}},
  journal = {Journal of Biosciences and Medicines},
  year = {2022},
  doi = {10.4236/jbm.2022.109021},
}
Figure